516 related articles for article (PubMed ID: 15559524)
1. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524
[No Abstract] [Full Text] [Related]
2. [Selective aldosterone blocking in heart failure. Eplerenone reduces the risk after infarction].
MMW Fortschr Med; 2003 Oct; 145(44):42-3. PubMed ID: 14655506
[No Abstract] [Full Text] [Related]
3. [More benefit in hypertension and high-grade reduction of the pump performance. Earlier beginning of therapy maximizes the benefit].
MMW Fortschr Med; 2004 Oct; 146(43):59. PubMed ID: 15559525
[No Abstract] [Full Text] [Related]
4. Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS.
Zhang Z; Mahoney EM; Kolm P; Spertus J; Caro J; Willke R; Weintraub WS
Am J Cardiovasc Drugs; 2010; 10(1):55-63. PubMed ID: 20104935
[TBL] [Abstract][Full Text] [Related]
5. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
MMW Fortschr Med; 2005 Jul; 147(27-28):44. PubMed ID: 16041942
[No Abstract] [Full Text] [Related]
6. Aldosterone antagonism in heart failure.
Richards AM; Nicholls MG
Lancet; 1999 Sep; 354(9181):789-90. PubMed ID: 10485716
[No Abstract] [Full Text] [Related]
7. [Aldosterone and its antagonists in heart failure].
Lopes ME; Le Corvoisier P; Tabet JY; Su JB; Badoual T; Cachin JC; Merlet P; Castaigne A; Hittinger L
Presse Med; 2003 Jan; 32(2):79-87. PubMed ID: 12653034
[TBL] [Abstract][Full Text] [Related]
8. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers.
Aaronson K
Health News; 2003 May; 9(5):4. PubMed ID: 12739453
[No Abstract] [Full Text] [Related]
9. [Combination drug therapy after myocardial infarction. Early aldosterone blocking protects risk patients].
MMW Fortschr Med; 2006 Jun; 148(24):48-9. PubMed ID: 16850812
[No Abstract] [Full Text] [Related]
10. [Aldosterone receptor blockade after acute myocardial infarction with heart failure].
Bauersachs J; Ertl G
Med Klin (Munich); 2006 Jun; 101(6):458-66. PubMed ID: 16767569
[TBL] [Abstract][Full Text] [Related]
11. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
MMW Fortschr Med; 2010 Dec; 152(48):12-3. PubMed ID: 21226226
[No Abstract] [Full Text] [Related]
12. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure].
Mundhenke M
Dtsch Med Wochenschr; 2006 Oct; 131(41):2297-8; author reply 2298. PubMed ID: 17036279
[No Abstract] [Full Text] [Related]
13. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study.
Krum H; Shi H; Pitt B; McMurray J; Swedberg K; van Veldhuisen DJ; Vincent J; Pocock S; Zannad F;
Circ Heart Fail; 2013 Jul; 6(4):711-8. PubMed ID: 23625945
[TBL] [Abstract][Full Text] [Related]
14. The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study.
Pitt B; Williams G; Remme W; Martinez F; Lopez-Sendon J; Zannad F; Neaton J; Roniker B; Hurley S; Burns D; Bittman R; Kleiman J
Cardiovasc Drugs Ther; 2001 Jan; 15(1):79-87. PubMed ID: 11504167
[No Abstract] [Full Text] [Related]
15. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
16. [Results of the RALES trial: good news for patients with heart failure and ... for health administrations].
Azpitarte Almagro J
Med Clin (Barc); 2000 Apr; 114(14):545-50. PubMed ID: 10846668
[No Abstract] [Full Text] [Related]
17. [Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study].
Watanabe J
Nihon Rinsho; 2007 Apr; 65 Suppl 4():543-6. PubMed ID: 17508588
[No Abstract] [Full Text] [Related]
18. Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure.
Ajani AE; Marwick TH; Krum H
Cardiovasc Revasc Med; 2006; 7(4):234-6. PubMed ID: 17174870
[TBL] [Abstract][Full Text] [Related]
19. [Drug treatment of chronic heart failure].
Böhm M; Werner N; Kindermann M
Clin Res Cardiol; 2006; 95 Suppl 4():36-54; quiz 55-6. PubMed ID: 16598606
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone blockade after myocardial infarction.
Hackam DG
CMAJ; 2003 Sep; 169(5):444. PubMed ID: 12952808
[No Abstract] [Full Text] [Related]
[Next] [New Search]
